NCT00002809View on ClinicalTrials.gov

Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 1996

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases

Interventions

BIOLOGICAL

anti-thymocyte globulin

BIOLOGICAL

filgrastim

BIOLOGICAL

sargramostim

BIOLOGICAL

therapeutic immune globulin

DRUG

cyclophosphamide

DRUG

methotrexate

DRUG

tacrolimus

PROCEDURE

allogeneic bone marrow transplantation

RADIATION

radiation therapy

Trial Locations (1)

19111-2442

Fox Chase-Temple Cancer Center, Philadelphia

All Listed Sponsors

lead

Temple University

OTHER

NCT00002809 - Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter